Literature DB >> 8995933

Quantification of duodenogastric reflux in Barrett's esophagus.

R Lirón1, P Parrilla, L F Martinez de Haro, A Ortiz, R Robles, J A Luján, T Fuente, B Andrés.   

Abstract

OBJECTIVES: Our objective was to assess the role of reflux of duodenal contents in the genesis of Barrett's esophagus. Therefore, we performed a study to quantify duodenogastric reflux, using 99mTc-HIDA quantification in gastric juice after continuous intravenous infusion of the same.
METHODS: The study contained 20 patients with Barrett's esophagus (10 uncomplicated and 10 complicated by ulcers and/or stenosis), 10 patients with peptic esophagitis without Barrett's esophagus (two grade I, four grade II, and four grade III, according to Savary-Miller), and 10 healthy volunteers who made up the control group. Comparisons were made between the groups.
RESULTS: When we considered the groups overall, we observed that the 20 patients with Barrett's esophagus had higher reflux rates (p < 0.01) than either the 10 patients with peptic esophagitis without Barrett's esophagus, or the 10 controls. Complicated Barrett's esophagus presented higher reflux rates than uncomplicated Barrett's esophagus, although the differences were not statistically significant. However, on analyzing the results after considering the groups case by case, we see that the mean reflux rate in the Barrett's esophagus groups is due to five patients presenting much higher rates than the rest.
CONCLUSIONS: Our results suggest that duodenogastric reflux might be involved in the appearance of Barrett's esophagus and its related complications, although only in certain cases. The pathogenesis of Barrett's esophagus is probably multifactorial, and other factors must be involved.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995933

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  12 in total

1.  The pathogenesis of Barrett's esophagus: a process in continuum or discontinuum.

Authors:  R C Fitzgerald; M J Farthing
Journal:  Curr Gastroenterol Rep       Date:  2000-12

2.  Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants.

Authors:  R C Fitzgerald; B A Onwuegbusi; M Bajaj-Elliott; I T Saeed; W R Burnham; M J G Farthing
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

3.  Expression of CXC receptor 1 and 2 in esophageal mucosa of patients with reflux esophagitis.

Authors:  Hajime Isomoto; Yusei Kanazawa; Yoshito Nishi; Chun-Yang Wen; Kenichiro Inoue; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

Review 4.  Detecting Bile Reflux-the Enigma of Bariatric Surgery.

Authors:  Thomas A Eldredge; Jennifer C Myers; George K Kiroff; Jonathan Shenfine
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

5.  Intestinal metaplasia in patients with columnar lined esophagus is associated with high levels of duodenogastroesophageal reflux.

Authors:  L Martinez de Haro ; A Ortiz; P Parrilla; V Munitiz; J Molina; J Bermejo; A Rios
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

6.  Medical, surgical, and endoscopic management of gastroesophageal reflux disease.

Authors:  Deron J Tessier
Journal:  Perm J       Date:  2009

7.  Primary duodenogastric reflux in children and adolescents.

Authors:  Dominique Hermans; Etienne-Marc Sokal; Jean-Marie Collard; Renato Romagnoli; Jean-Paul Buts
Journal:  Eur J Pediatr       Date:  2003-06-26       Impact factor: 3.183

8.  Comparative evaluation of intragastric bile acids and hepatobiliary scintigraphy in the diagnosis of duodenogastric reflux.

Authors:  Teng-Fei Chen; Praveen K Yadav; Rui-Jin Wu; Wei-Hua Yu; Chang-Qin Liu; Hui Lin; Zhan-Ju Liu
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

9.  The histological and immunohistochemical aspects of bile reflux in patients with gastroesophageal reflux disease.

Authors:  Andreas Nakos; Georgios Kouklakis; Michail Pitiakoudis; Petros Zezos; Eleni Efraimidou; Alexandra Giatromanolaki; Alexandros Polychronidis; Nikolaos Liratzopoulos; Efthimios Sivridis; Konstantinos Simopoulos
Journal:  Gastroenterol Res Pract       Date:  2011-07-24       Impact factor: 2.260

10.  Immune and Inflammatory Responses in GERD and Lansoprazole.

Authors:  Hajime Isomoto; Yoshito Nishi; Yusei Kanazawa; Saburo Shikuwa; Yohei Mizuta; Kenichiro Inoue; Shigeru Kohno
Journal:  J Clin Biochem Nutr       Date:  2007-09       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.